Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 2
2014 3
2015 6
2016 1
2017 2
2018 5
2019 3
2020 1
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting.
Verbiest A, Couchy G, Job S, Zucman-Rossi J, Caruana L, Lerut E, Oyen R, de ReyniĆØs A, Laguerre B, Rioux-Leclercq N, Wozniak A, Joniau S, Van Poppel H, Van Den Eynde K, Beuselinck B. Verbiest A, et al. Among authors: zucman rossi j, beuselinck b. Clin Genitourin Cancer. 2018 Jun;16(3):e605-e612. doi: 10.1016/j.clgc.2017.10.017. Epub 2017 Nov 7. Clin Genitourin Cancer. 2018. PMID: 29239846
Molecular subtypes and prognosis in RCC.
Beuselinck B, Fridman WH, Zucman-Rossi J. Beuselinck B, et al. Among authors: zucman rossi j. Aging (Albany NY). 2015 Apr;7(4):219-20. doi: 10.18632/aging.100736. Aging (Albany NY). 2015. PMID: 25885644 Free PMC article. No abstract available.
Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications.
Roussel E, Kinget L, Verbiest A, Boeckx B, Zucman-Rossi J, Couchy G, Caruso S, Baldewijns M, Joniau S, Van Poppel H, Lambrechts D, Albersen M, Beuselinck B. Roussel E, et al. Among authors: zucman rossi j, beuselinck b. Acta Oncol. 2021 Nov;60(11):1499-1506. doi: 10.1080/0284186X.2021.1962971. Epub 2021 Aug 27. Acta Oncol. 2021. PMID: 34448678
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors.
Verbiest A, Renders I, Caruso S, Couchy G, Job S, Laenen A, Verkarre V, Rioux-Leclercq N, Schƶffski P, Vano Y, Elaidi RT, Lerut E, Albersen M, Oudard S, Fridman WH, SautĆØs-Fridman C, AlbigĆØs L, Wozniak A, Zucman-Rossi J, Beuselinck B. Verbiest A, et al. Among authors: zucman rossi j, beuselinck b. Clin Genitourin Cancer. 2019 Oct;17(5):e981-e994. doi: 10.1016/j.clgc.2019.05.009. Epub 2019 May 25. Clin Genitourin Cancer. 2019. PMID: 31229459
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
Beuselinck B, Verbiest A, Couchy G, Job S, de Reynies A, Meiller C, Albersen M, Verkarre V, Lerut E, MƩjean A, Patard JJ, Laguerre B, Rioux-Leclercq N, Schƶffski P, Oudard S, Zucman-Rossi J. Beuselinck B, et al. Among authors: zucman rossi j. Acta Oncol. 2018 Apr;57(4):498-508. doi: 10.1080/0284186X.2017.1388927. Epub 2017 Nov 2. Acta Oncol. 2018. PMID: 29095068
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy.
Verbiest A, Couchy G, Job S, Caruana L, Lerut E, Oyen R, de ReyniĆØs A, Tosco L, Joniau S, Van Poppel H, Van Raemdonck D, Van Den Eynde K, Wozniak A, Zucman-Rossi J, Beuselinck B. Verbiest A, et al. Among authors: zucman rossi j, beuselinck b. Eur Urol. 2018 Oct;74(4):474-480. doi: 10.1016/j.eururo.2018.01.042. Epub 2018 Feb 17. Eur Urol. 2018. PMID: 29463434
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials.
Roussel E, Verbiest A, Kinget L, Boeckx B, Zucman-Rossi J, Couchy G, Caruso S, Job S, de ReyniĆØs A, De Wever L, Baldewijns M, Van Poppel H, Joniau S, Lambrechts D, Albersen M, Beuselinck B. Roussel E, et al. Among authors: zucman rossi j, beuselinck b. Clin Genitourin Cancer. 2021 Dec;19(6):e382-e394. doi: 10.1016/j.clgc.2021.07.005. Epub 2021 Jul 10. Clin Genitourin Cancer. 2021. PMID: 34362692
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.
Verbiest A, Lambrechts D, Van Brussel T, Couchy G, Wozniak A, MĆ©jean A, Lerut E, Oudard S, Verkarre V, Job S, de Reynies A, Machiels JP, Patard JJ, Zucman-Rossi J, Beuselinck B. Verbiest A, et al. Among authors: zucman rossi j, beuselinck b. Clin Genitourin Cancer. 2018 Aug;16(4):266-273. doi: 10.1016/j.clgc.2018.01.013. Epub 2018 Feb 5. Clin Genitourin Cancer. 2018. PMID: 29503246
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC).
Becht E, Giraldo NA, Beuselinck B, Job S, Marisa L, Vano Y, Oudard S, Zucman-Rossi J, Laurent-Puig P, SautĆØs-Fridman C, de ReyniĆØs A, Fridman WH. Becht E, et al. Among authors: zucman rossi j, beuselinck b. Oncoimmunology. 2015 Aug 7;4(12):e1049804. doi: 10.1080/2162402X.2015.1049804. eCollection 2015 Dec. Oncoimmunology. 2015. PMID: 26587318 Free PMC article.
MicroRNAs Targeting HIF-2Ī±, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2Ī± Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.
Kinget L, Roussel E, Verbiest A, Albersen M, RodrĆ­guez-Antona C, GraƱa-Castro O, Inglada-PĆ©rez L, Zucman-Rossi J, Couchy G, Job S, de ReyniĆØs A, Laenen A, Baldewijns M, Beuselinck B. Kinget L, et al. Among authors: zucman rossi j, beuselinck b. Cancers (Basel). 2021 Jun 21;13(12):3099. doi: 10.3390/cancers13123099. Cancers (Basel). 2021. PMID: 34205829 Free PMC article.
25 results